Current Overview on Hypercoagulability in COVID-19

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought many unique pathologies, such as coagulopathy, prompting a desperate need for effective management. COVID-19-associated coagulopathy (CAC) can cause various thromboem...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Cardiovasc Drugs
Asıl Yazarlar: Singhania, Namrata, Bansal, Saurabh, Nimmatoori, Divya P., Ejaz, Abutaleb A., McCullough, Peter A., Singhania, Girish
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2020
Konular:
Leading Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7398761/
https://ncbi.nlm.nih.gov/pubmed/32748336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40256-020-00431-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller